Tissue Regenix Group (LON:TRX) Stock Price Crosses Below 200 Day Moving Average – Time to Sell?

by · The Cerbat Gem

Tissue Regenix Group plc (LON:TRX – Get Free Report)’s stock price passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 61.32 ($0.77) and traded as low as GBX 58.03 ($0.73). Tissue Regenix Group shares last traded at GBX 58.03 ($0.73), with a volume of 26 shares trading hands.

Tissue Regenix Group Price Performance

The company has a debt-to-equity ratio of 35.69, a current ratio of 3.74 and a quick ratio of 2.36. The stock’s 50 day moving average price is GBX 57.69 and its two-hundred day moving average price is GBX 61.22. The firm has a market capitalization of £41.40 million, a price-to-earnings ratio of -5,812.50 and a beta of 1.61.

About Tissue Regenix Group

(Get Free Report)

Tissue Regenix Group plc, a medical technology company, develops and commercializes platform technologies in the field of bone graft substitutes and soft tissue in the United States and internationally. The company operates through dCELL, BioRinse, and GBM-V segments. It also provides dCELL technology, a soft tissue decellularisation process that removes DNA and other cellular material from animal and human soft tissue to repair diseased or damaged body parts; and BioRinse technology, a natural bone filler solution for osteoinductivity to stimulate and regenerate native bone growth.

Featured Articles